Literature DB >> 12238572

Effect of age on antibody titer to Mycoplasma pneumoniae.

Florian Daxboeck1, Karl Kircher, Robert Krause, Harald Heinzl, Christoph Wenisch, Gerold Stanek.   

Abstract

Between January 1996 and September 1999, 13,650 serum samples from 12,337 patients were examined for antibodies to Mycoplasma pneumoniae at the Institute of Hygiene, University Hospital Vienna in the course of routine diagnosis. Antibody determination was performed by means of the microparticle agglutination assay Serodia Myco II. Overall, positive results (antibody titer > or = 1:40) were obtained in 2028 patients (16.4%). Age details were available for analysis in 2016 positive patients. Young children (< or = 9 y) who tested positive showed a geometric mean titer of 1:137.9 (95% confidence interval: 117.7-161.4). The geometric mean titers of positive patients decreased significantly with age (Spearman's correlation coefficient -0.20; p < 0.0001). Only 1/87 patients with serological evidence of M. pneumoniae infection aged > or = 70 y showed a titer of > or = 1:320. These data highlight the fact that, in the elderly, acute M. pneumoniae infection has to be considered in cases with slightly elevated antibody titers, which are usually referred to as borderline in children and young adults.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12238572     DOI: 10.1080/00365540110089836

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

1.  Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard".

Authors:  Matthias F C Beersma; Kristien Dirven; Alje P van Dam; Kate E Templeton; Eric C J Claas; Herman Goossens
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

2.  Mycoplasma pneumoniae infection associated with urticarial vasculitis mimicking adult-onset Still's disease.

Authors:  Janet Dua; Anupama Nandagudi; Nurhan Sutcliffe
Journal:  Rheumatol Int       Date:  2011-09-15       Impact factor: 2.631

Review 3.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

4.  Recombinase Polymerase Amplification Combined with Real-Time Fluorescent Probe for Mycoplasma pneumoniae Detection.

Authors:  Tingting Jiang; Yacui Wang; Weiwei Jiao; Yiqin Song; Qing Zhao; Tianyi Wang; Jing Bi; Adong Shen
Journal:  J Clin Med       Date:  2022-03-23       Impact factor: 4.241

5.  Massive empyema caused by Mycoplasma pneumoniae in an adult: a case report.

Authors:  Mony Shuvy; Moshe Rav-Acha; Uzi Izhar; Merav Ron; Ran Nir-Paz
Journal:  BMC Infect Dis       Date:  2006-02-01       Impact factor: 3.090

6.  The diagnostic value of serological tests and real-time polymerase chain reaction in children with acute Mycoplasma pneumoniae infection.

Authors:  Qing-Ling Li; He-Ting Dong; Hui-Ming Sun; Xin-Xing Zhang; Wen-Jing Gu; Li Huang; Yu-Qing Wang; Yong-Dong Yan; Wei Ji; Chuang-Li Hao; Can-Hong Zhu; Zheng-Rong Chen
Journal:  Ann Transl Med       Date:  2020-03

7.  Predicting anti-RhD titers in donors: Boostering response and decline rates are personal.

Authors:  Anneke S de Vos; C Ellen van der Schoot; Dimitris Rizopoulos; Mart P Janssen
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.